JP2023537994A5 - - Google Patents

Info

Publication number
JP2023537994A5
JP2023537994A5 JP2023509840A JP2023509840A JP2023537994A5 JP 2023537994 A5 JP2023537994 A5 JP 2023537994A5 JP 2023509840 A JP2023509840 A JP 2023509840A JP 2023509840 A JP2023509840 A JP 2023509840A JP 2023537994 A5 JP2023537994 A5 JP 2023537994A5
Authority
JP
Japan
Prior art keywords
aryl
alkyl
cycloalkyl
heteroaryl
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023509840A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023537994A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/045446 external-priority patent/WO2022035902A1/en
Publication of JP2023537994A publication Critical patent/JP2023537994A/ja
Publication of JP2023537994A5 publication Critical patent/JP2023537994A5/ja
Pending legal-status Critical Current

Links

JP2023509840A 2020-08-11 2021-08-10 プロテアソームエンハンサーおよびその使用 Pending JP2023537994A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063064262P 2020-08-11 2020-08-11
US63/064,262 2020-08-11
PCT/US2021/045446 WO2022035902A1 (en) 2020-08-11 2021-08-10 Proteasome enhancers and uses thereof

Publications (2)

Publication Number Publication Date
JP2023537994A JP2023537994A (ja) 2023-09-06
JP2023537994A5 true JP2023537994A5 (enExample) 2024-08-20

Family

ID=83103405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509840A Pending JP2023537994A (ja) 2020-08-11 2021-08-10 プロテアソームエンハンサーおよびその使用

Country Status (7)

Country Link
US (1) US20230286982A1 (enExample)
EP (1) EP4196121A4 (enExample)
JP (1) JP2023537994A (enExample)
AU (1) AU2021325024A1 (enExample)
CA (1) CA3191436A1 (enExample)
MX (1) MX2023001759A (enExample)
WO (1) WO2022035902A1 (enExample)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238216A (en) * 1963-06-20 1966-03-01 Res Lab Dr C Janssen N V Substituted 1, 3, 8-triaza-spiro (4, 5) decanes
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
FR2373967A1 (fr) * 1976-12-20 1978-07-13 Wellcome Found Derives de l'imidazoline et leur emploi comme agents pesticides
NZ249040A (en) * 1992-02-06 1997-06-24 Merrell Dow Pharma Triphenyl azacycloalkane derivatives; treatment of drug resistance
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
US6011035A (en) * 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
US6686370B2 (en) * 1999-12-06 2004-02-03 Euro-Celtique S.A. Triazospiro compounds having nociceptin receptor affinity
US6482829B2 (en) * 2000-06-08 2002-11-19 Hoffmann-La Roche Inc. Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor
GB0211759D0 (en) * 2002-05-22 2002-07-03 Glaxo Group Ltd Novel compounds
CN101472924A (zh) * 2006-06-20 2009-07-01 惠氏公司 Kv1.5钾通道抑制剂
CN101838269B (zh) * 2009-03-18 2012-09-26 中国人民解放军军事医学科学院毒物药物研究所 1,3,8-三氮杂-螺[4.5]癸烷-4-酮类化合物及其医药用途
WO2011143444A2 (en) * 2010-05-14 2011-11-17 President And Fellows Of Harvard College Diphenylbutypiperidine autophagy inducers
IT201800007580A1 (it) * 2018-07-27 2020-01-27 Maria Cecilia Hospital Spa Composti 1,3,8-triazaspiro e loro uso come medicamenti

Similar Documents

Publication Publication Date Title
JP6907173B2 (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
ES2777626T3 (es) Sulfonilureas y compuestos relacionados y uso de los mismos
ES2670984T3 (es) Composiciones y métodos para modular receptores X farnesoides
KR100704215B1 (ko) 8-아자프로스타글란딘 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
AU2017289038B2 (en) Immunomodulator compounds
ES2670571T3 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis B
ES2281565T3 (es) Inhibidores de la integrasa de vih de tipo dihidroxipirimidina carboxamida.
ES2556822T3 (es) Derivados de trifluorometil-oxadiazol novedosos y su uso en el tratamiento de enfermedad
ES2707534T3 (es) Compuestos útiles como inmunomoduladores
ES2791340T3 (es) Derivado de urea o sal farmacológicamente aceptable del mismo
US20140309192A1 (en) Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
ES2282857T3 (es) Derivados de bifenilcarboxamida y su uso como inhibidores de quinasa p38.
JP2020525513A (ja) 癌および他の疾患を治療するためのatf4阻害剤としてのn−(3−(2−(4−クロロフェノキシ)アセトアミドビシクロ[1.1.1]ペンタン−1−イル)−2−シクロブタン−1−カルボキサミド誘導体および関連化合物
JP2004503549A (ja) 生体等配電子性ベンズアミド誘導体およびそのアポb−100分泌阻害剤としての使用
WO2002022563A1 (en) Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
ES2405542T3 (es) Agente terapéutico para el infarto cerebral
CN113372342B (zh) 蛋白降解靶向嵌合体及其应用
KR20250109233A (ko) 코로나바이러스 감염을 치료 또는 예방하기 위한 프로테아제 억제제로서의 2-아미노-n-(4-아미노-3,4-디옥소-1-(2-옥소피롤리딘-3-일)부탄-2-일)벤즈아미드 유도체
AU2006243393A1 (en) 3 -mono- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
JP2023537994A5 (enExample)
JP5497665B2 (ja) 2−アミノ−2−フェニル−アルカノール誘導体、それらの製造、及びそれらを含む医薬組成物
EP2054407A2 (en) Pyrolidine derivatives useful against diseases that depends on activity of renin
WO2014182688A1 (en) Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
JP2004175738A (ja) 医薬組成物